Skip to main content
. 2016 Oct 13;4:e2577. doi: 10.7717/peerj.2577

Table 1. Characteristics of the study population (N = 123).

Variables N (%)
Age mean ± SD 61.84 (±11.10)
Age groups (%)
Age < 65 years 73 (59.35%)
Age ≥ 65 years 50 (40.65%)
Gender (%)
Female 81 (65.85%)
Male 42 (34.15%)
Marital Status (%)
Single 19 (15.45%)
Married 53 (49.09%)
Living together 25 (20.33%)
Divorced 7 (5.69%)
Widowed 19 (15.45%)
Years of disease (%)
1–10 years 61 (49.59%)
≥10 years 62 (50.41%)
Treatment (%)
No pharmacological treatment 10 (8.13%)
OAD 74 (60.16%)
Insulin 8 (6.50%)
OAD plus insulin 31 (25.20%)
HbA1c (%) 8.23 ± 2.19
HbA1c (%) by ranges
HbA1c < 7% 43 (35.83%)
HbA1c = 7–8% 23 (19.17%)
HbA1c = 8–9% 22 (18.33%)
HbA1c = 9–10% 9 (7.5%)
HbA1c > 10% 23 (19.17%)
LDL(mg/dL), mean± SD 107.61 ± 39.66
Blood pressure (mmHg), mean (%)
Without hypertension 77 (62.60%)
With hypertension 46 (37.40%)
BMI, mean± SD 28.5 ± 4.71
IPAQ
HEPA active 67 (56.30%)
Minimally active 25 (21.01%)
Inactive 27 (22.69%)
EATDM-III 56.69 ± 11.28
Depression
Yes 41 (33.33%)
No 82 (66.67%)

Notes.

HbA1c
Glycosylated hemoglobin
BMI
Body mass index
IPAQ
International Physical Activity Questionnaire
OAD
Oral antidiabetics
EATDM-III
Escala de adherencia al tratamiento de la diabetes mellitus tipo II